Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
1,753
Views
83
CrossRef citations to date
0
Altmetric
Reviews

Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance

Hung-Chih YangDepartment of Microbiology, National Taiwan University College of Medicine, Taipei 10002, Taiwan, China;Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei 10002, Taiwan, China;Department of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan, China
&
Jia-Horng KaoGraduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei 10002, Taiwan, China;Department of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan, China;Hepatitis Research Center, National Taiwan University Hospital, Taipei 10002, Taiwan, China;Department of Medical Research, National Taiwan University Hospital, Taipei 10002, Taiwan, ChinaCorrespondence[email protected]
Pages 1-7 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

  • Kao JH, Chen PJ, Chen DS.Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. Adv Cancer Res2010;108: 21–72.
  • Dienstag JL.Hepatitis B virus infection. N Engl J Med2008;359: 1486–1500.
  • Lin CL, Kao JH.Hepatitis B viral factors and treatment responses in chronic hepatitis B. J Formosan Med Assoc2013;112: 302–311.
  • Kao JH.HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon? Liver Int2014;34 Suppl 1: 112–119.
  • Ahn SH, Chan HL, Chen PJ et al.Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions. Hepatol Int2010;4: 386–395.
  • Liang Y, Jiang J, Su M et al.Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy. Aliment Pharmacol Ther2011;34: 344–352.
  • Perez-Cameo C, Pons M, Esteban R.New therapeutic perspectives in HBV: when to stop NAs. Liver Int2014;34 Suppl 1: 146–153.
  • Zoulim F.New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol2005;42: 302–308.
  • Michalak TI, Pasquinelli C, Guilhot S, Chisari FV.Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest1994;94: 907.
  • Rehermann B, Ferrari C, Pasquinelli C, Chisari FV.The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med1996;2: 1104–1108.
  • Loriot MA, Marcellin P, Walker F et al.Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol1997;27: 251–258.
  • Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP.Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology1998;27: 1736–1742.
  • Summers J, Mason WS.Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell1982;29: 403–415.
  • Nassal M.Hepatitis B viruses: reverse transcription a different way. Virus Res2008;134: 235–249.
  • Seeger C, Mason WS.Hepatitis B virus biology. Microbiol Mol Biol Rev2000;64: 51–68.
  • Yan H, Zhong G, Xu G et al.Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife2012;1: e00049.
  • Moolla N, Kew M, Arbuthnot P.Regulatory elements of hepatitis B virus transcription. J Viral Hepat2002;9: 323–331.
  • Quasdorff M, Protzer U.Control of hepatitis B virus at the level of transcription. J Viral Hepat2010;17: 527–536.
  • Tuttleman JS, Pourcel C, Summers J.Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell1986;47: 451–460.
  • Wu TT, Coates L, Aldrich CE, Summers J, Mason WS.In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology1990;175: 255–261.
  • Newbold JE, Xin H, Tencza M et al.The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol1995;69: 3350–3357.
  • Zhang YY, Zhang BH, Theele D, Litwin S, Toll E, Summers J.Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc Natl Acad Sci USA2003;100: 12372–12377.
  • Gao W, Hu J.Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein. J Virol2007;81: 6164–6174.
  • Guo H, Jiang D, Zhou T, Cuconati A, Block TM, Guo JT.Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol2007;81: 12472–12484.
  • Guo H, Mao R, Block TM, Guo JT.Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses. J Virol2010;84: 387–396.
  • Jones SA, Boregowda R, Spratt TE, Hu J.In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase. J Virol2012;86: 5134–5150.
  • Werle-Lapostolle B, Bowden S, Locarnini S et al.Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology2004;126: 1750–1758.
  • Chu CM, Liaw YF.Hepatitis B surface antigen seroclearance during chronic HBV infection. Antivir Ther2010;15: 133–143.
  • Marusawa H, Uemoto S, Hijikata M et al.Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology2000;31: 488–495.
  • Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P.Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”? Hepatology2001;34: 194–203.
  • Raimondo G, Pollicino T, Cacciola I, Squadrito G.Occult hepatitis B virus infection. J Hepatol2007;46: 160–170.
  • Yeo W, Chan TC, Leung NW et al.Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol2009;27: 605–611.
  • Hsu C, Tsou HH, Lin SJ et al.Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. Hepatology2014;59: 2092–2100.
  • Raimondo G, Pollicino T, Romano L, Zanetti AR.A 2010 update on occult hepatitis B infection. Pathol Biol (Paris)2010;58: 254–257.
  • Civitico GM, Locarnini SA.The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures. Virology1994;203: 81–89.
  • Moraleda G, Saputelli J, Aldrich CE, Averett D, Condreay L, Mason WS.Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol1997;71: 9392–9399.
  • Dandri M, Burda MR, Will H, Petersen J.Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA. Hepatology2000;32: 139–146.
  • Hantz O, Parent R, Durantel D, Gripon P, Guguen-Guillouzo C, Zoulim F.Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J Gen Virol2009;90(Pt 1): 127–135.
  • Zhu Y, Yamamoto T, Cullen J et al.Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol2001;75: 311–322.
  • Addison WR, Walters KA, Wong WW et al.Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J Virol2002;76: 6356–6363.
  • Le Guerhier F, Pichoud C, Guerret S et al.Characterization of the antiviral effect of 2′,3′-dideoxy-2′, 3′-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model. Antimicrob Agents Chemother2000;44: 111–122.
  • Le Guerhier F, Pichoud C, Jamard C et al.Antiviral activity of beta-L-2′,3′-dideoxy-2′,3′-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus. Antimicrob Agents Chemother2001;45: 1065–1077.
  • Reaiche GY, Le Mire MF, Mason WS, Jilbert AR.The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Virology2010;406: 286–292.
  • Siliciano JD, Siliciano RF.A long-term latent reservoir for HIV-1: discovery and clinical implications. J Antimicrob Chemother2004;54: 6–9.
  • Kock J, Schlicht HJ.Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J Virol1993;67: 4867–4874.
  • Delmas J, Schorr O, Jamard C et al.Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro. Antimicrob Agents Chemother2002;46: 425–433.
  • Kock J, Baumert TF, Delaney WE 4th, Blum HE, von Weizsacker F.Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes. Hepatology 200;38: 1410–1418.
  • Boni C, Penna A, Bertoletti A et al.Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol2003;39: 595–605.
  • Boni C, Laccabue D, Lampertico P et al.Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Gastroenterology2012;143: 963–973.
  • Sung JJ, Wong ML, Bowden S et al.Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology2005;128: 1890–1897.
  • Wong DK, Yuen MF, Yuan H et al.Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology2004;40: 727–737.
  • Chisari FV, Mason WS, Seeger C.Virology. Comment on “Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA”. Science2014;344: 1237.
  • Chan HL, Wong VW, Tse AM et al.Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin Gastroenterol Hepatol2007;5: 1462–1468.
  • Tseng TC, Liu CJ, Su TH et al.Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. Gastroenterology2011;141: 517–525.
  • Tseng TC, Kao JH.Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog. J Gastroenterol2013;48: 13–21.
  • Wong DK, Yuen MF, Ngai VW, Fung J, Lai CL.One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels. Antivir Ther2006;11: 909–916.
  • Perrillo R.Benefits and risks of interferon therapy for hepatitis B. Hepatology2009;49(5 Suppl): S103–S111.
  • Allweiss L, Volz T, Lutgehetmann M et al.Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. J Hepatol2014;60: 500–507.
  • Lucifora J, Xia Y, Reisinger F et al.Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science2014: 343: 1221–1228.
  • Wursthorn K, Lutgehetmann M, Dandri M et al.Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology2006;44: 675–684.
  • Hagiwara S, Kudo M, Osaki Y et al.Impact of peginterferon alpha-2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B. J Med Virol2013;85: 987–995.
  • Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H.Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA1996;93: 4398–4402.
  • Tsiang M, Rooney JF, Toole JJ, Gibbs CS.Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy. Hepatology1999;29: 1863–1869.
  • Lewin SR, Ribeiro RM, Walters T et al.Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology2001;34: 1012–1020.
  • Wolters LM, Hansen BE, Niesters HG, DeHertogh D, de Man RA.Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B. J Hepatol2002;37: 137–144.
  • Jenuwein T, Allis CD.Translating the histone code. Science2001;293: 1074–1080.
  • Lande-Diner L, Zhang J, Ben-Porath I et al.Role of DNA methylation in stable gene repression. J Biol Chem2007;282: 12194–12200.
  • Li B, Carey M, Workman JL.The role of chromatin during transcription. Cell2007;128: 707–719.
  • Bock CT, Schranz P, Schroder CH, Zentgraf H.Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus genes1994;8: 215–229.
  • Bock CT, Schwinn S, Locarnini S et al.Structural organization of the hepatitis B virus minichromosome. J Mol Biol2001;307: 183–196.
  • Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M.Control of cccDNA function in hepatitis B virus infection. J Hepatol2009;51: 581–592.
  • Pollicino T, Belloni L, Raffa G et al.Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology2006;130: 823–837.
  • Belloni L, Pollicino T, de Nicola F et al.Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci USA2009;106: 19975–19979.
  • Vivekanandan P, Thomas D, Torbenson M.Hepatitis B viral DNA is methylated in liver tissues. J Viral Hepat2008;15: 103–107.
  • Zhang Y, Li C, Zhang Y et al.Comparative analysis of CpG islands among HBV genotypes. PloS One2013;8: e56711.
  • Vivekanandan P, Thomas D, Torbenson M.Methylation regulates hepatitis B viral protein expression. J Infect Dis2009;199: 1286–1291.
  • Guo Y, Li Y, Mu S, Zhang J, Yan Z.Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication. J Med Virol2009;81: 1177–1183.
  • Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ.Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology2006;44: 694–702.
  • Volz T, Lutgehetmann M, Wachtler P et al.Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology2007;133: 843–852.
  • Belloni L, Allweiss L, Guerrieri F et al.IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest2012;122: 529–537.
  • Liu F, Campagna M, Qi Y et al.Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes. PLoS Pathog2013;9: e1003613.
  • Dandri M, Petersen J.Hepatitis B virus cccDNA clearance: killing for curing? Hepatology2005;42: 1453–1455.
  • Guidotti LG, Ando K, Hobbs MV et al.Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA1994;91: 3764–3768.
  • Guidotti LG.Viral clearance without destruction of infected cells during acute HBV infection. Science1999;284: 825–829.
  • Guidotti LG, Chisari FV.Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol2001;19: 65–91.
  • Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV.CD8+ T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol2010;184: 287–295.
  • McClary H, Koch R, Chisari FV, Guidotti LG.Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol2000;74: 2255–2264.
  • Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV.Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity1996;4: 25–36.
  • Jacquard AC, Nassal M, Pichoud C et al.Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection. Antimicrob Agents Chemother2004;48: 2683–2692.
  • Zhu Y, Cullen JM, Aldrich CE et al.Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus. Virology2004;327: 26–40.
  • Turelli P, Mangeat B, Jost S, Vianin S, Trono D.Inhibition of hepatitis B virus replication by APOBEC3G. Science2004;303: 1829.
  • Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS.APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol2010;17: 222–229.
  • Kitamura K, Wang Z, Chowdhury S, Simadu M, Koura M, Muramatsu M.Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA. PLoS Pathog2013;9: e1003361.
  • Thimme R, Wieland S, Steiger C et al.CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol2003;77: 68–76.
  • Fourel I, Cullen JM, Saputelli J et al.Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J Virol1994;68: 8321–8330.
  • Guo JT, Zhou H, Liu C et al.Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J Virol2000;74: 1495–1505.
  • Summers J, Jilbert AR, Yang W et al.Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc Natl Acad Sci USA2003;100: 11652–11659.
  • Summers J, Mason WS.Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy. Proc Natl Acad Sci USA2004;101: 638–640.
  • Mason WS, Jilbert AR, Summers J.Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. Proc Natl Acad Sci USA2005;102: 1139–1144.
  • Schiffer JT, Swan DA, Stone D, Jerome KR.Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach. PLoS Comput Biol2013;9: e1003131.
  • Cradick TJ, Keck K, Bradshaw S, Jamieson AC, McCaffrey AP.Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. Mol Ther2010;18: 947–954.
  • Bloom K, Ely A, Mussolino C, Cathomen T, Arbuthnot P.Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther2013;21: 1889–1897.
  • Chen J, Zhang W, Lin J et al.An efficient antiviral strategy for targeting hepatitis B virus genome using Transcription Activator-Like Effector Nucleases. Mol Ther2013: 22: 303–311.
  • Mali P, Esvelt KM, Church GM.Cas9 as a versatile tool for engineering biology. Nat Methods2013;10: 957–963.
  • Penna A, Chisari FV, Bertoletti A et al.Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med1991;174: 1565–1570.
  • Nayersina R, Fowler P, Guilhot S et al.HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol1993;150: 4659–4671.
  • Rehermann B, Fowler P, Sidney J et al.The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med1995;181: 1047–1058.
  • Bohne F, Protzer U.Adoptive T-cell therapy as a therapeutic option for chronic hepatitis B. J Viral Hepat2007;14 Suppl 1: 45–50.
  • Krebs K, Bottinger N, Huang LR et al.T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice. Gastroenterology2013;145: 456–465.
  • Schmidt WN, Nelson DR, Pawlotsky JM, Sherman KE, Thomas DL, Chung RT.Direct-acting antiviral agents and the path to interferon independence. Clin Gastroenterol Hepatol2014;12: 728–737.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.